- Top Workplaces
- Adverum Biotechnologies
Adverum Biotechnologies
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.
Mission
To establish gene therapy as a new standard of care for the leading causes of vision loss.
Additional Culture Details
Team Adverum is passionate about our science and the patients we will help. We are here and do the work we do for our patients. The foundation of our culture is built on collaboration. We share a mission and a vision for the future of our patients and we know we can't get there without partnering together to innovate and problem-solve. Beyond our patients and our teamwork, at Adverum, inclusion and diversity are at our core. We believe in the power of being your authentic self. We strive to create the space which allows for everyone in our Adverum community to not only feel safe but encouraged to speak, learn from each other, grow in their professions and be the very best versions of themselves no matter what their age, gender, ethnic background, origin, religion or sexual orientation.
Values
- Lead With Integrity
- We take individual and collective responsibility to advance evidence-based science as we embark on a bold mission.
Recent Awards
Company Snapshots
